{"mainPropery":{"diseaseId":10637,"diseaseName":"Anaplastic oligoastrocytoma","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/10637/anaplastic-oligoastrocytoma","synonyms":[],"synonyms-with-source":[],"identifiers":[{"identifierType":"UMLS","identifierId":"C0431108"}]},"diseaseCategories":[{"diseaseTypeId":1,"diseaseTypeName":"Rare Cancers"}],"organizations":[],"resource descriptions":[{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Anaplastic+oligoastrocytoma%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Anaplastic oligoastrocytoma. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1543,"resourceId":2171,"resourceName":"National Cancer Institute","descriptionText":"The <a href='http://www.cancer.gov/cancertopics/pdq/treatment/adultbrain/HealthProfessional#Section_300' target='_blank'>National Cancer Institute</a> provides the most current information on cancer for patients, health professionals, and the general public.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/Orphanet:251663' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":6469,"questionText":"What is anaplastic oligoastrocytoma?","answerText":"<strong>Anaplastic oligoastrocytoma</strong> is&nbsp;a brain <a href=\"http://www.cancer.gov/dictionary?CdrID=46634\" target=_blank>tumor</a> that forms when two types of <a href=\"http://ghr.nlm.nih.gov/glossary=cell\" target=_blank>cells</a> in the brain, called&nbsp;<a href=\"http://www.cancer.gov/dictionary?CdrID=540447\" target=_blank>oligodendrocytes</a> and <a href=\"http://www.cancer.gov/dictionary?CdrID=269436\" target=_blank>astrocytes</a>, rapidly increase in number to form a mass.&nbsp; These brain cells are known as <a href=\"http://www.cancer.gov/dictionary?CdrID=269440\" target=_blank>glial cells</a>, which normally protect and support nerve cells in the brain.&nbsp; Because an oligoastrocytoma is made up of a combination of two cell types, it is known as a <a href=\"http://www.cancer.gov/dictionary?CdrID=45344\" target=_blank>mixed glioma</a>.[3644]&nbsp;&nbsp;An oligoastrocytoma is described as <a href=\"http://www.cancer.gov/dictionary?CdrID=45591\" target=_blank>anaplastic</a>&nbsp;when the tumor grows quickly and the cancer cells within the tumor have the potential to spread into surrounding brain tissue or to more distant parts of the body.&nbsp; Oligoastrocytomas usually occur in a part of the brain called the <a href=\"http://www.nlm.nih.gov/medlineplus/ency/imagepages/19236.htm\" target=_blank>cerebrum</a> and are diagnosed in adults between the ages of 30 and 50.[5532]&nbsp; The exact cause of this condition is unknown.[3645][5532]","dateModified":"2012-10-08T06:41:00"},"basicQuestions":[{"questionId":6465,"questionText":"What are the symptoms of an oligoastrocytoma?","answerText":"The symptoms of oligoastrocytoma depend on the size of the tumor and its exact location in the brain.&nbsp; The most common symptoms include headaches, <a href=\"http://www.nlm.nih.gov/medlineplus/seizures.html\" target=_blank>seizures</a>, and changes in personality.[5532]","dateModified":"2012-10-05T08:09:00","resourceClassificationName":"Symptoms","references":[]},{"questionId":6466,"questionText":"What treatments are available for anaplastic oligoastrocytoma?","answerText":"Treatment of anaplastic oligoastrocytoma depends on the size and location of the tumor.&nbsp; If possible, treatment begins with surgery to remove as much of the tumor as possible.&nbsp; <a href=\"http://www.cancer.gov/dictionary?CdrID=45214\" target=_blank>Chemotherapy</a> or <a href=\"http://www.cancer.gov/dictionary?CdrID=44971\" target=_blank>radiation therapy</a> may be needed&nbsp;following surgery to destroy any remaining cancer cells.[5533]","dateModified":"2012-10-08T06:34:00","resourceClassificationName":"Treatment","references":[{"referenceId":5533,"authors":"National Comprehensive Cancer Network","articleTitle":"Central Nervous System Cancers","bookWebsiteJournalTitle":"NCCN Clinical Practics Guidelines in Oncology","date":"2012","url":"http://www.nccn.org/professionals/physician_gls/pdf/cns.pdf","dateAccessed":"2012-10-04T00:00:00"}]}],"references":[],"relatedDiseases":[],"gardCases":[{"caseId":36756,"abbreviatedInquiry":"I am trying to find out more information on anaplastic&nbsp;oligoastrocytoma.","caseQuestions":[{"questionId":6469,"questionText":"What is anaplastic oligoastrocytoma?","answerText":"<strong>Anaplastic oligoastrocytoma</strong> is&nbsp;a brain <a href=\"http://www.cancer.gov/dictionary?CdrID=46634\" target=_blank>tumor</a> that forms when two types of <a href=\"http://ghr.nlm.nih.gov/glossary=cell\" target=_blank>cells</a> in the brain, called&nbsp;<a href=\"http://www.cancer.gov/dictionary?CdrID=540447\" target=_blank>oligodendrocytes</a> and <a href=\"http://www.cancer.gov/dictionary?CdrID=269436\" target=_blank>astrocytes</a>, rapidly increase in number to form a mass.&nbsp; These brain cells are known as <a href=\"http://www.cancer.gov/dictionary?CdrID=269440\" target=_blank>glial cells</a>, which normally protect and support nerve cells in the brain.&nbsp; Because an oligoastrocytoma is made up of a combination of two cell types, it is known as a <a href=\"http://www.cancer.gov/dictionary?CdrID=45344\" target=_blank>mixed glioma</a>.[3644]&nbsp;&nbsp;An oligoastrocytoma is described as <a href=\"http://www.cancer.gov/dictionary?CdrID=45591\" target=_blank>anaplastic</a>&nbsp;when the tumor grows quickly and the cancer cells within the tumor have the potential to spread into surrounding brain tissue or to more distant parts of the body.&nbsp; Oligoastrocytomas usually occur in a part of the brain called the <a href=\"http://www.nlm.nih.gov/medlineplus/ency/imagepages/19236.htm\" target=_blank>cerebrum</a> and are diagnosed in adults between the ages of 30 and 50.[5532]&nbsp; The exact cause of this condition is unknown.[3645][5532]","dateModified":"2012-10-08T06:41:00","references":[{"referenceId":3644,"authors":"","articleTitle":"Oligoastrocytoma","bookWebsiteJournalTitle":"National Cancer Institute","date":"","url":"http://www.cancer.gov/dictionary/?CdrID=321382","dateAccessed":"2012-10-04T00:00:00"},{"referenceId":3645,"authors":"","articleTitle":"Oligodendroglioma and Oligoastrocytoma","bookWebsiteJournalTitle":"American Brain Tumor Association","date":"","url":"http://www.abta.org/siteFiles/SitePages/BE237E81490FDB6286AF83C71D912A42.pdf","dateAccessed":"2012-10-04T00:00:00"},{"referenceId":5532,"authors":"American Brain Tumor Association","articleTitle":"Oligoastrocytoma","bookWebsiteJournalTitle":"Understanding Brain Tumors","date":"2012","url":"http://www.abta.org/understanding-brain-tumors/types-of-tumors/oligoastrocytoma.html","dateAccessed":"2012-10-04T00:00:00"}]},{"questionId":6465,"questionText":"What are the symptoms of an oligoastrocytoma?","answerText":"The symptoms of oligoastrocytoma depend on the size of the tumor and its exact location in the brain.&nbsp; The most common symptoms include headaches, <a href=\"http://www.nlm.nih.gov/medlineplus/seizures.html\" target=_blank>seizures</a>, and changes in personality.[5532]","dateModified":"2012-10-05T08:09:00","resourceClassificationName":"Symptoms","references":[]},{"questionId":6466,"questionText":"What treatments are available for anaplastic oligoastrocytoma?","answerText":"Treatment of anaplastic oligoastrocytoma depends on the size and location of the tumor.&nbsp; If possible, treatment begins with surgery to remove as much of the tumor as possible.&nbsp; <a href=\"http://www.cancer.gov/dictionary?CdrID=45214\" target=_blank>Chemotherapy</a> or <a href=\"http://www.cancer.gov/dictionary?CdrID=44971\" target=_blank>radiation therapy</a> may be needed&nbsp;following surgery to destroy any remaining cancer cells.[5533]","dateModified":"2012-10-08T06:34:00","resourceClassificationName":"Treatment","references":[{"referenceId":5533,"authors":"National Comprehensive Cancer Network","articleTitle":"Central Nervous System Cancers","bookWebsiteJournalTitle":"NCCN Clinical Practics Guidelines in Oncology","date":"2012","url":"http://www.nccn.org/professionals/physician_gls/pdf/cns.pdf","dateAccessed":"2012-10-04T00:00:00"}]},{"questionId":6467,"questionText":"Are there any research studies for individuals with anaplastic oligoastrocytoma?","answerText":"<p>The U.S. National Institutes of Health, through the National Library of Medicine, developed <a href=\"http://www.clinicaltrials.gov/\">ClinicalTrials.gov</a> to provide patients, family members, and members of the public with current information on clinical research studies. Currently,&nbsp;30 clinical trials are identified as enrolling individuals with oligoastrocytoma.&nbsp; To find these trials, click on the link above and use \"oligoastrocytoma\" as your search term. After you click on a study, review its \"eligibility\" criteria to determine its appropriateness. Use the study’s contact information to learn more. Check this site often for regular updates.</p>\r\n<p>You can also contact the Patient Recruitment and Public Liaison (PRPL) Office at the National Institutes of Health (NIH). We recommend calling <strong>1-800-411-1222</strong> to speak with a specialist, who can help determine if someone is eligible for any clinical trials.&nbsp; <br></font></span><br>Patient Recruitment and Public Liaison Office<br>NIH Clinical Center<br>Bethesda, Maryland 20892-2655<br>Toll-free: 1-800-411-1222<br>Fax: 301-480-9793<br>E-mail: </font><a href=\"mailto:prpl@mail.cc.nih.gov\">prpl@mail.cc.nih.gov</font></a><br>Web site:&nbsp; </font><a href=\"http://clinicalcenter.nih.gov/\">http://clinicalcenter.nih.gov/</font></a></p>\r\n<p>If someone is interested in enrolling in a clinical trial, helpful general information on clinical trials can be found at the <a href=\"http://clinicaltrials.gov/ct2/info/understand\">ClinicalTrials.gov Web page</a>. Resources on many charitable or special-fare flights to research and treatment sites and low-cost hospitality accommodations for outpatients and family members, as well as ambulance services, are listed on the Web site of the <a href=\"http://rarediseases.info.nih.gov/Resources.aspx?PageID=8\">Office of Rare Diseases Research (ORDR)</a>, part of the National Institutes of Health.</p>","dateModified":"2012-10-08T06:44:00","references":[]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[],"medicalProducts":[],"EncodedName":"Anaplastic_oligoastrocytoma"}